लोड हो रहा है...

Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma

The objective was to leverage tumor size data from preclinical experiments to propose a model of tumor growth and angiogenesis inhibition for the analysis of pazopanib efficacy in renal cell carcinoma (RCC) patients. We analyzed tumor data in mice with RCC CAKI‐2 cell line treated with pazopanib. Cl...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:CPT Pharmacometrics Syst Pharmacol
मुख्य लेखकों: Ouerdani, A, Struemper, H, Suttle, AB, Ouellet, D, Ribba, B
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2015
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716582/
https://ncbi.nlm.nih.gov/pubmed/26783502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12001
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!